Polar Capital Biotechnology R EUR (IE00B3VXGD32)

68.84 -0.36 (-0.52%) EUR  |  Aug 27 2026
More

IE00B3VXGD32 Total Assets Under Management

Total Assets Under Management Chart

Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets Under Management Chart
Start Trial

Historical Total Assets Under Management Data

View and export this data back to 2025. Start Trial.
Date Value
March 31, 2026 3.056B
February 28, 2026 2.964B
January 31, 2026 2.829B
December 31, 2025 2.786B
November 30, 2025 2.802B
October 31, 2025 2.546B
Date Value
September 30, 2025 2.268B
August 31, 2025 2.089B
July 31, 2025 1.896B
June 30, 2025 1.756B
May 31, 2025 1.700B
April 30, 2025 1.792B

Total Assets Under Management Definition

Total Assets Under Management (AUM) is the total market value of the investments that a fund holds.

Read full definition.

Total Assets Under Management Range, Past 5 Years

View Total Assets Under Management Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets Under Management Benchmarks

View Total Assets Under Management Benchmarks
Start Trial
Allianz Biotechnologie - A - EUR 277.10M
DWS ESG Biotech LC 369.15M
ERSTE STOCK BIOTEC EUR R01 (T) 280.81M
MEDICAL BioHealth EUR 977.59M
Pictet-Biotech-HP EUR 2.333B

Total Assets Under Management Excel Add-In Codes

View Total Assets Under Management Excel Add-In Codes
Start Trial
Metric Code: total_assets_under_management
Latest Data Point: =YCP("M:IE00B3VXGD32", "total_assets_under_management")
Last 5 Data Points: =YCS("M:IE00B3VXGD32", "total_assets_under_management", -4)
To find the codes for any of our securities and financial metrics, see our Complete Excel Reference.